Please ensure Javascript is enabled for purposes of website accessibility

Chimerix(CMRX)

Nasdaq Global Market

CMRX
Chimerix Stock Quote
$6.63 -$0.31 -4.5%
Price as of July 30, 2021, 4:00 p.m. ET View Interactive CMRX Charts

Chimerix Inc is a biopharmaceutical company that develops and commercializes oral antivirals. It has two compounds in clinical development: CMX001 and CMX157.

Interactive Chart


Compare CMRX Stock to Peers


Symbol Last Price Market Cap % Δ 1 Yr % Δ 5 Yr
CMRX
Chimerix
$6.63 $572M 113.2% 62.5%
CWBHF
$3.20 $555M -8.2%
OGI
$3.25 $971M 100.6% 130.5%
ANAB
$22.98 $629M 28.0%
VLNCF
$2.16 $502M 38.5%

News & Analysis: Chimerix

All

Market Moves

Earnings







Why Chimerix Inc. Is Up Big Today

Shares are recovering today from their massive sell-off, but the company's near-term future remains a mystery.


Worst Small-Cap Stocks of 2015

Here's why a brand management company, a marine shipper, and a biopharmaceutical were the worst-performing small company stocks in 2015.



Why Chimerix's Shares Collapsed Today

The biopharma's shares imploded after the company's lead product candidate missed its primary endpoint in a late-stage study.